Jennifer Cochran: Guided missiles target cancer

For years, cancer treatment was confined to three flawed strategies. You could cut it out with a scalpel, you could burn it out with radiation, or you could kill it with chemicals. “Today, we are amid a renaissance in cancer treatment,” says Stanford bioengineer Jennifer Cochran. “We are creating designer proteins and using them to deliver drugs or to harness the immune system to help stop this killer dead in its tracks.”

On this episode of The Future of Everything radio show, Cochran and host, fellow bioengineer Russ Altman, explore the very latest in the science of cancer treatment. 

Related | Jennifer Cochran, Shriram chair and associate professor of bioengineering and, by courtesy, associate professor of chemical engineering.

Related | Russ Altman, Kenneth Fong professor and professor of bioengineering, of genetics, of medicine (general medical discipline), of biomedical data science and, by courtesy, of computer science.